Benjamin Ortiz to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Benjamin Ortiz has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.185
-
Geng B, Bachert C, Busse WW, Gevaert P, Lee SE, Niederman MS, Chen Z, Lu X, Khokhar FA, Kapoor U, Pandit-Abid N, Jacob-Nara JA, Rowe PJ, Deniz Y, Ortiz B. Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies. J Allergy Clin Immunol Pract. 2022 03; 10(3):732-741.
Score: 0.185